BN Business News
Добавить компанию →
Этот перевод готовится. Пока мы временно показываем оригинальную версию на английском языке.

Энергетика и окружающая среда · 18.08.20152 мин чтения

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Локальный автоматический перевод · Язык оригинального источника

Краткое содержание

NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 8-9, 2015. A sample of agenda items to be discussed during the public session includes: (1) A discussion on training and experience for alpha and beta emitters; (2) a discussion on Title 10 of the Code of Federal Regulations (10 CFR) section 35.1000 licensing guidance for the use of iodine-125 and palladium-103 seeds for localization of non-palpable lesions; (3) a presentation on the proposed revisions to the 10 CFR 35.1000 licensing guidance for Yttrium-90 microspheres brachytherapy; (4) a status update on the decommissioning funding plan requirements for germanium-68/gallium-68 generators; (5) a discussion on the project and upcoming workshops related to patients who are administered radionuclides; (6) a discussion on NUREG 1556, Volume 9, "Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licensees;" (7) an update on the current 10 CFR part 35 rulemaking effort; and (8) a presentation on the proposed revisions to the NRC's Abnormal Occurrence Reporting Criteria Policy Statement. The agenda is subject to change. The current agenda and a

Язык оригинального источника: Federal Register — Nuclear Regulatory CommissionОткрыть исходное сообщение →

Другие тематические подборки

Деловая аналитика →